Clinical Trial Update: Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the pharmacokinetics of ganciclovir in patients undergoing continuous renal replacement therapy; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Kidney Injury
• Multiple Organ Dysfunction Syndrome

Drugs mentioned

• GANCICLOVIR (GANCICLOVIR SODIUM)

Snippet

Sponsor: University of Oslo School of Pharmacy | Conditions: Acute Renal Failure, Cytomegalovirus Infections | Phase 4 | Status: TERMINATED